On the contrary, LRRC25 levels are decreased in primary lower-grade glioma and many other tumor cell lines at both mRNA and protein levels (Zhang et al., 2020), and therefore may be protective against tumors. This evidence concerns the gene LRRC25 and central nervous system cancer.